Connection

Tanya Turan to Humans

Back to Details
This is a "connection" page, showing publications Tanya Turan has written about Humans.
Tanya Turan
Connection Strength
1.046
Humans
  1. The CASSISS Randomized Clinical Trial. Stroke. 2023 01; 54(1):286-289.
    View in: PubMed
    Score: 0.032
  2. Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. Neurology. 2022 03 22; 98(12):486-498.
    View in: PubMed
    Score: 0.031
  3. Asymptomatic Intracranial Atherosclerotic Stenosis: The Risk Above the Carotids. J Am Coll Cardiol. 2021 08 10; 78(6):572-574.
    View in: PubMed
    Score: 0.029
  4. Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist. J Neuroophthalmol. 2020 12; 40(4):463-471.
    View in: PubMed
    Score: 0.028
  5. Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105362.
    View in: PubMed
    Score: 0.028
  6. Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial. Stroke. 2020 10; 51(10):2960-2971.
    View in: PubMed
    Score: 0.027
  7. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.025
  8. Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
    View in: PubMed
    Score: 0.024
  9. Phentermine associated recurrent intracerebral hemorrhage. J Neurol Sci. 2018 10 15; 393:135-137.
    View in: PubMed
    Score: 0.024
  10. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.023
  11. Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. Neurologist. 2017 Nov; 22(6):241-244.
    View in: PubMed
    Score: 0.023
  12. Large Artery Atherosclerosis: Extracranial and Intracranial. Semin Neurol. 2017 06; 37(3):307-315.
    View in: PubMed
    Score: 0.022
  13. Development of a high resolution MRI intracranial atherosclerosis imaging phantom. J Neurointerv Surg. 2018 Feb; 10(2):143-149.
    View in: PubMed
    Score: 0.022
  14. Light-induced Hemiplegia, an Atypical Case of Retinal Steal Syndrome. Neurologist. 2017 Mar; 22(2):57-60.
    View in: PubMed
    Score: 0.021
  15. Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. J Stroke Cerebrovasc Dis. 2017 Mar; 26(3):488-493.
    View in: PubMed
    Score: 0.021
  16. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
    View in: PubMed
    Score: 0.021
  17. Vessel and Vessel Wall Imaging. Front Neurol Neurosci. 2016; 40:109-123.
    View in: PubMed
    Score: 0.021
  18. Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
    View in: PubMed
    Score: 0.021
  19. The importance of age and menopausal status in endometrial complex hyperplasia with atypia. J Obstet Gynaecol. 2016; 36(1):102-5.
    View in: PubMed
    Score: 0.019
  20. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
    View in: PubMed
    Score: 0.019
  21. Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
    View in: PubMed
    Score: 0.019
  22. Intracranial atherosclerosis: correlation between in-vivo 3T high resolution MRI and pathology. Atherosclerosis. 2014 Dec; 237(2):460-3.
    View in: PubMed
    Score: 0.018
  23. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.017
  24. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.017
  25. High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke. 2013 Jan; 44(1):287-92.
    View in: PubMed
    Score: 0.016
  26. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
    View in: PubMed
    Score: 0.016
  27. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2011 Apr; 21(2):e159-61.
    View in: PubMed
    Score: 0.014
  28. 10 questions about intracranial atherosclerotic stenosis. Neurologist. 2010 Nov; 16(6):400-5.
    View in: PubMed
    Score: 0.014
  29. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010 Aug; 41(8):1636-40.
    View in: PubMed
    Score: 0.014
  30. Treatment of atherosclerotic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):2257-61.
    View in: PubMed
    Score: 0.012
  31. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.012
  32. Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
    View in: PubMed
    Score: 0.011
  33. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007 Jun 12; 115(23):2969-75.
    View in: PubMed
    Score: 0.011
  34. Central retinal venous occlusion and cerebral venous thrombosis. Arch Neurol. 2007 Apr; 64(4):609; author reply 609.
    View in: PubMed
    Score: 0.011
  35. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1432-8.
    View in: PubMed
    Score: 0.010
  36. Stroke in pregnancy. Neurol Clin. 2004 Nov; 22(4):821-40.
    View in: PubMed
    Score: 0.009
  37. Posttraumatic cerebrospinal fluid hypertension and hypotension. Arch Neurol. 2004 Jul; 61(7):1124-5.
    View in: PubMed
    Score: 0.009
  38. Change in Smoking Behavior and Outcome After Ischemic Stroke: Post-Hoc Analysis of the SPS3 Trial. Stroke. 2023 Apr; 54(4):921-927.
    View in: PubMed
    Score: 0.008
  39. Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke. Stroke. 2022 04; 53(4):1085-1103.
    View in: PubMed
    Score: 0.008
  40. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
    View in: PubMed
    Score: 0.008
  41. Hypertensive Disorders of Pregnancy With and Without Prepregnancy Hypertension Are Associated With Incident Maternal Kidney Disease Subsequent to Delivery. Hypertension. 2022 04; 79(4):844-854.
    View in: PubMed
    Score: 0.008
  42. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
    View in: PubMed
    Score: 0.008
  43. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. Stroke. 2021 10; 52(10):e635-e645.
    View in: PubMed
    Score: 0.007
  44. Incident Heart Failure Within the First and Fifth Year after Delivery Among Women With Hypertensive Disorders of Pregnancy and Prepregnancy Hypertension in a Diverse Population. J Am Heart Assoc. 2021 09 07; 10(17):e021616.
    View in: PubMed
    Score: 0.007
  45. Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105918.
    View in: PubMed
    Score: 0.007
  46. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 07; 52(7):e364-e467.
    View in: PubMed
    Score: 0.007
  47. High-resolution vessel wall imaging after mechanical thrombectomy. Neuroradiol J. 2021 Dec; 34(6):593-599.
    View in: PubMed
    Score: 0.007
  48. White Matter Hyperintensity and Cardiovascular Disease Outcomes in the SPRINT MIND Trial. J Stroke Cerebrovasc Dis. 2021 Jun; 30(6):105764.
    View in: PubMed
    Score: 0.007
  49. Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension. J Am Heart Assoc. 2021 02; 10(5):e018155.
    View in: PubMed
    Score: 0.007
  50. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.007
  51. Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk. Neurosurgery. 2020 06 01; 86(6):755-762.
    View in: PubMed
    Score: 0.007
  52. The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic. Neurology. 2020 07 07; 95(1):29-36.
    View in: PubMed
    Score: 0.007
  53. Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg. 2010 May; 51(5):1081-7.
    View in: PubMed
    Score: 0.007
  54. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
    View in: PubMed
    Score: 0.007
  55. Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities? J Stroke Cerebrovasc Dis. 2019 Nov; 28(11):104371.
    View in: PubMed
    Score: 0.006
  56. Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure. J Am Coll Cardiol. 2018 11 13; 72(20):2542-2544.
    View in: PubMed
    Score: 0.006
  57. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90.
    View in: PubMed
    Score: 0.006
  58. Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. Int J Stroke. 2017 10; 12(7):770-778.
    View in: PubMed
    Score: 0.005
  59. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
    View in: PubMed
    Score: 0.005
  60. High-Resolution Magnetic Resonance Imaging Evidence for Intracranial Vessel Wall Inflammation Following Endovascular Thrombectomy. J Stroke Cerebrovasc Dis. 2017 May; 26(5):e96-e98.
    View in: PubMed
    Score: 0.005
  61. Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):403-410.
    View in: PubMed
    Score: 0.005
  62. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
    View in: PubMed
    Score: 0.005
  63. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol. 2016 Mar; 73(3):308-15.
    View in: PubMed
    Score: 0.005
  64. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54.
    View in: PubMed
    Score: 0.005
  65. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
    View in: PubMed
    Score: 0.005
  66. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-360.
    View in: PubMed
    Score: 0.005
  67. Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology. 2015 Dec 15; 85(24):2090-7.
    View in: PubMed
    Score: 0.005
  68. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.005
  69. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation. 2015 Sep 22; 132(12):1157-213.
    View in: PubMed
    Score: 0.005
  70. Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke. 2015 Sep; 46(9):2562-7.
    View in: PubMed
    Score: 0.005
  71. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.005
  72. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
    View in: PubMed
    Score: 0.005
  73. Undifferentiated uterine carcinoma: analysis of eighteen cases. J Obstet Gynaecol. 2015 May; 35(4):372-6.
    View in: PubMed
    Score: 0.005
  74. Racial differences in poststroke rehabilitation utilization and functional outcomes. Arch Phys Med Rehabil. 2015 Jan; 96(1):84-90.
    View in: PubMed
    Score: 0.005
  75. Comparison of endovascular treatment approaches for acute ischemic stroke: cost effectiveness, technical success, and clinical outcomes. J Neurointerv Surg. 2015 Sep; 7(9):666-70.
    View in: PubMed
    Score: 0.004
  76. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014; 37(6):417-22.
    View in: PubMed
    Score: 0.004
  77. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
    View in: PubMed
    Score: 0.004
  78. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):e28-e292.
    View in: PubMed
    Score: 0.004
  79. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013 Nov; 12(11):1106-14.
    View in: PubMed
    Score: 0.004
  80. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.004
  81. Intracranial stenting: SAMMPRIS. Stroke. 2013 Jun; 44(6 Suppl 1):S41-4.
    View in: PubMed
    Score: 0.004
  82. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Jul; 44(7):2064-89.
    View in: PubMed
    Score: 0.004
  83. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.004
  84. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):143-52.
    View in: PubMed
    Score: 0.004
  85. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
    View in: PubMed
    Score: 0.004
  86. Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz. Stroke. 2012 Oct; 43(10):2806-9.
    View in: PubMed
    Score: 0.004
  87. MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina. J S C Med Assoc. 2012 Oct-Dec; 108(5):128-31.
    View in: PubMed
    Score: 0.004
  88. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.004
  89. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg. 2013 Nov; 5(6):528-33.
    View in: PubMed
    Score: 0.004
  90. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications. J Neurointerv Surg. 2013 Nov; 5(6):518-22.
    View in: PubMed
    Score: 0.004
  91. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Dec; 43(12):3442-53.
    View in: PubMed
    Score: 0.004
  92. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
    View in: PubMed
    Score: 0.004
  93. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.004
  94. CT perfusion-guided patient selection for endovascular treatment of acute ischemic stroke is safe and effective. J Neurointerv Surg. 2012 Jul; 4(4):261-5.
    View in: PubMed
    Score: 0.004
  95. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.004
  96. Intracerebral hemorrhage: an unusual presentation of neurosarcoidosis. Neurologist. 2011 Sep; 17(5):292-6.
    View in: PubMed
    Score: 0.004
  97. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
    View in: PubMed
    Score: 0.004
  98. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.004
  99. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.003
  100. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
    View in: PubMed
    Score: 0.003
  101. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg. 2009 Jul; 1(1):35-9.
    View in: PubMed
    Score: 0.003
  102. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.